Changes to the Executive Board of Carl Zeiss AG

• As fiscal year 2025/26 begins, Carl Zeiss AG is reorganizing its Executive Board under President and CEO Andreas Pecher.
• Dr. Jochen Peter, responsible for the ZEISS Industrial Quality & Research (IQR) segment, will step down from the Executive Board of Carl Zeiss AG at his own request and on the best of terms on 30 September 2025 to take on new professional challenges. Effective 1 October 2025, Dr. Marc Wawerla, who is currently Head of the ZEISS Industrial Quality Solutions (IQS) strategic business unit and President and CEO of Carl Zeiss Industrielle Messtechnik GmbH, will become a new member of the Executive Board of Carl Zeiss AG for the IQR segment.
• Susan-Stefanie Breitkopf, member of the Executive Board and Chief Transformation Officer (CTO) of Carl Zeiss AG, will leave the company on 30 September 2025 at her own request and on the best of terms to take on new professional challenges. The responsibilities within the CTO's remit will be reallocated within the Executive Board of Carl Zeiss AG in line with business and customer needs and the transformation will continue at pace.

Effective 1 October 2025, Carl Zeiss AG will be making changes to its Executive Board members and reorganizing its remits.

Dr. Jochen Peter has decided not to renew his contract for another term as a member of the Executive Board of Carl Zeiss AG with responsibility for the ZEISS Industrial Quality & Research (IQR) segment. He notified the Supervisory Board of Carl Zeiss AG about this. On 30 September 2025, he will leave the company at his own request and on the best of terms to take on new professional challenges outside the ZEISS Group. He will remain available to Carl Zeiss AG until the end of 2025 to complete ongoing projects. "The Supervisory Board of Carl Zeiss AG regrets Dr. Peter's decision. He has excellently positioned and aligned the Industrial Quality & Research segment. He succeeded in tapping into important new market potential at a time when sales markets were facing massive challenges and sustainable climate protection was becoming increasingly relevant. In addition, he has made an important contribution to the development of the ZEISS Group. We would like to thank him for his dedication and for his very successful work. We wish him all the best for his future and continue to wish him every success," said Dr. Michael Bolle, Chairman of the Supervisory Board of Carl Zeiss AG.

The Supervisory Board of Carl Zeiss AG has appointed Dr. Marc Wawerla as his successor and as a new member of the Executive Board effective 1 October 2025. Dr. Wawerla is currently Head of the ZEISS Industrial Quality Solutions (IQS) strategic business unit and President and CEO of Carl Zeiss Industrielle Messtechnik GmbH. "The Supervisory Board of Carl Zeiss AG is pleased to be able to appoint Dr. Marc Wawerla as a suitable successor from within the company. He has excellent global market knowledge and has demonstrated his comprehensive management and leadership skills in a wide variety of roles at ZEISS. Dr. Wawerla has already made significant contributions to the development of the Industrial Quality & Research segment in recent years, in particular to the transformation of industrial metrology within key sectors that are digitalizing their production and decarbonizing their portfolio. In appointing him, ZEISS is underlining the importance of continuity in the transformation of key customer segments. We wish him every success in his new role and all the best," said Dr. Michael Bolle.

Another change on the Executive Board of Carl Zeiss AG will be the departure of Chief Transformation Officer and Executive Board member Susan-Stefanie Breitkopf on 30 September 2025 at her own request and on the best of terms to take on new professional challenges outside the ZEISS Group. "The Supervisory Board regrets Susan-Stefanie Breitkopf's decision to leave the ZEISS Group. She set the course for an efficient and effective implementation of our digital transformation in a highly dynamic, systematic and structured way, impacting our corporate culture. She headed up the development toward a data- and process-oriented organization, the major expansion of the digital capability spectrum and the digital infrastructure," said Dr. Michael Bolle. "We would like to thank Susan-Stefanie Breitkopf for her dedication and the extremely successful work she has done. We wish her all the best for her future and continued success." The responsibilities within the CTO’s remit will be reallocated within the Executive Board of Carl Zeiss AG in line with business and customer needs, and the transformation will continue at pace. The upcoming implementation phase of the transformation programs will be carried out in the segments, countries and business supporting functions respectively. Susan-Stefanie Breitkopf will remain available to Carl Zeiss AG until the end of 2025 to complete ongoing projects.

From 1 October 2025, the Executive Board of Carl Zeiss AG will consist of the following members: Andreas Pecher (President and CEO), Stefan Müller (Chief Financial Officer), Maximilian Foerst (Head of the ZEISS Medical Technology segment), Sven Hermann (Head of the ZEISS Consumer Markets segment), Dr. Frank Rohmund (Head of the ZEISS Semiconductor Manufacturing Technology segment) and Dr. Marc Wawerla (Head of the ZEISS Industrial Quality & Research segment).

Susan-Stefanie Breitkopf has been a member of the Executive Board and Chief Transformation Officer of Carl Zeiss AG since 2022. She joined the ZEISS Group in 2021. From 2017, she worked as Managing Director and Director of Labor Relations at the Currenta Group, a former joint venture of Bayer AG and Lanxess AG which ran major chemical industrial sites in North Rhine-Westphalia. From 2015, Susan-Stefanie Breitkopf worked for Covestro AG. She began her professional career in leadership roles at Lanxess AG in 2004. Prior to this, she worked as a consultant. She graduated with a degree in law from the University of Hamburg.

Dr. Jochen Peter has been a member of the Executive Board of Carl Zeiss AG since 2017 and is responsible for the Industrial Quality & Research segment. He joined the company in 2011 as Head of the Strategic Corporate Development Group of the ZEISS Group. He then became Head of Technology & Innovation at Vision Care. From 2015, he headed up the Industrial Metrology business group at ZEISS. Prior to his career at ZEISS, he worked at the Boston Consulting Group as a consultant specializing in the automotive industry, technology companies and medical technology, spending several years in the US. He began his professional career in 2000 as a development engineer at BMW AG, while at the same time he completed his doctorate at the Fraunhofer Institute for High-Speed Dynamics. Dr. Peter studied mechanical and process engineering in Germany at the Technical University of Kaiserslautern and business administration at the University of Hagen.

Dr. Marc Wawerla has been working for the ZEISS Group since 2010. In 2012, he became Head of ZEISS Vision Care in India, and assumed responsibility for the Vision Technology Solutions business unit in 2014. In 2015, he became Chief Operating Officer and, as such, was responsible for the global production network of ZEISS Vision Care. From 2018, he promoted the digitalization of the ZEISS Consumer Markets segment as Digital Transformation Officer (DTO) and was responsible for research and development at ZEISS Vision Care as Chief Technology Officer (CTO). In 2020, he took over the management of the strategic business unit, ZEISS Industrial Quality Solutions (IQS), and was appointed President and CEO of Carl Zeiss Industrielle Messtechnik GmbH. Dr. Marc Wawerla studied mechanical engineering at KIT in Karlsruhe, Germany, and received his doctorate in engineering at the wbk Institute of Production Engineering.